This archive report was first published on 26 August 2021.
On August 26, 2021, Kenya's Ministry of Health reported 35 new COVID-19 deaths, including 34 cases that were filed from data audited in July and August. This brings the country's cumulative fatalities to 4,635.
Health Cabinet Secretary Mutahi Kagwe stated that 817 more people tested positive for the virus out of a sample size of 6,350, representing a positivity rate of 12.9 percent.
Of the new cases, 644 patients had recovered from the disease, including 85 who were discharged from healthcare facilities and 559 who were released from home-based isolation and care programs.
As of August 26, total recoveries stood at 216,771.
So far, 2,649,820 people had been inoculated, with 2.9 percent of adults fully vaccinated.
According to Kagwe, the uptake of the second dose among those who received their first dose was at 42.9 percent, with the majority being males at 55 percent and females at 45 percent.
Nairobi accounted for the highest cases at 215, followed by Kiambu (110), Nakuru (45), Kericho (44), Uasin Gishu (35), and Machakos (32).
Kenya was set to receive 4.5 million doses of various COVID-19 vaccines by mid-September to boost the ongoing vaccination exercise.
The government was currently administering AstraZeneca and Moderna vaccines across the country.
Speaking during a virtual meeting with journalists on Wednesday, Vaccine Deployment Taskforce Chairperson Willis Akhwale announced that 1.7 million doses of Pfizer and 2 million doses of Sinopharm would arrive in September.
Akhwale also stated that another 393,600 doses of the Johnson and Johnson vaccine would arrive by the end of August, in addition to 500,000 doses expected in the coming weeks.
